• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗血管生成肽血管抑素会破坏细胞膜。

The anti-angiogenic peptide anginex disrupts the cell membrane.

作者信息

Pilch Jan, Franzin Carla M, Knowles Lynn M, Ferrer Fernando J, Marassi Francesca M, Ruoslahti Erkki

机构信息

Burnham Institute for Medical Research, 10901 N. Torrey Pines Rd., La Jolla, CA 92037, USA.

出版信息

J Mol Biol. 2006 Mar 3;356(4):876-85. doi: 10.1016/j.jmb.2005.12.006. Epub 2005 Dec 20.

DOI:10.1016/j.jmb.2005.12.006
PMID:16403516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2922962/
Abstract

Anginex is a synthetic beta-sheet peptide with anti-angiogenic and anti-tumor activity. When added to cultured endothelial cells at concentrations ranging from 2.5 microM to 25 microM, anginex induced cell death, which was reflected by a strong increase of subdiploid cells and fragments, loss of cellular ATP, and LDH release. Cytotoxicity remained the same whether cells were treated with anginex at 4 degrees C or at 37 degrees C. At low temperatures, fluorescein-conjugated anginex accumulated on the endothelial surface, but did not reach into the cytoplasm, indicating that the cell membrane is the primary target for the peptide. Within minutes of treatment, anginex caused endothelial cells to take up propidium iodide and undergo depolarization, both parameters characteristic for permeabilization of the cell membrane. This process was amplified when cells were activated with hydrogen peroxide. Red blood cell membranes were essentially unaffected by anginex. Anginex bound lipid bilayers with high affinity and with a clear preference for anionic over zwitterionic phospholipids. Structural studies by circular dichroism and solid-state nuclear magnetic resonance showed that anginex forms a beta-sheet and adopts a unique and highly ordered conformation upon binding to lipid membranes. This is consistent with lipid micellization or the formation of pore-forming beta-barrels. The data suggest that the cytotoxicity of anginex stems from its ability to target and disrupt the endothelial cell membrane, providing a possible explanation for the angiostatic activity of the peptide.

摘要

血管抑制素是一种具有抗血管生成和抗肿瘤活性的合成β-折叠肽。当以2.5微摩尔至25微摩尔的浓度添加到培养的内皮细胞中时,血管抑制素会诱导细胞死亡,这表现为亚二倍体细胞和碎片的大量增加、细胞内三磷酸腺苷(ATP)的丧失以及乳酸脱氢酶(LDH)的释放。无论细胞在4℃还是37℃下用血管抑制素处理,细胞毒性都保持不变。在低温下,荧光素偶联的血管抑制素在内皮表面积累,但未进入细胞质,这表明细胞膜是该肽的主要作用靶点。在处理后的几分钟内,血管抑制素使内皮细胞摄取碘化丙啶并发生去极化,这两个参数都是细胞膜通透性的特征。当细胞用过氧化氢激活时,这个过程会被放大。红细胞膜基本上不受血管抑制素的影响。血管抑制素以高亲和力结合脂质双层,并且明显偏好阴离子磷脂而非两性离子磷脂。通过圆二色性和固态核磁共振进行的结构研究表明,血管抑制素形成β-折叠,并在与脂质膜结合时采用独特且高度有序的构象。这与脂质胶束化或形成成孔β-桶一致。数据表明,血管抑制素的细胞毒性源于其靶向并破坏内皮细胞膜的能力,这为该肽的血管生成抑制活性提供了一种可能的解释。

相似文献

1
The anti-angiogenic peptide anginex disrupts the cell membrane.抗血管生成肽血管抑素会破坏细胞膜。
J Mol Biol. 2006 Mar 3;356(4):876-85. doi: 10.1016/j.jmb.2005.12.006. Epub 2005 Dec 20.
2
Anginex-conjugated liposomes for targeting of angiogenic endothelial cells.用于靶向血管生成内皮细胞的血管抑素缀合脂质体。
Bioconjug Chem. 2007 May-Jun;18(3):785-90. doi: 10.1021/bc060316h. Epub 2007 Mar 23.
3
Beta-sheet is the bioactive conformation of the anti-angiogenic anginex peptide.β-折叠是抗血管生成血管抑素肽的生物活性构象。
Biochem J. 2003 Jul 1;373(Pt 1):281-8. doi: 10.1042/BJ20030295.
4
Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein.克隆编码血管抑制素血管抑素的人工基因:从设计肽到功能性重组蛋白。
Biochem Biophys Res Commun. 2005 Aug 12;333(4):1261-8. doi: 10.1016/j.bbrc.2005.06.029.
5
Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent.安格宁作为一种有前途的抗血管生成和抗肿瘤药物的进展和前景。
Peptides. 2012 Dec;38(2):457-62. doi: 10.1016/j.peptides.2012.09.007. Epub 2012 Sep 14.
6
The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.设计的抗血管生成肽Anginex靶向肿瘤内皮细胞,并在动物模型中抑制肿瘤生长。
FASEB J. 2002 Dec;16(14):1991-3. doi: 10.1096/fj.02-0509fje. Epub 2002 Oct 18.
7
Anti-tumor activity of the novel angiogenesis inhibitor anginex.新型血管生成抑制剂Anginex的抗肿瘤活性
Cancer Lett. 2003 May 8;194(1):55-66. doi: 10.1016/s0304-3835(03)00015-6.
8
Anginex, a designed peptide that inhibits angiogenesis.血管抑制素,一种抑制血管生成的人工合成肽。
Biochem J. 2001 Mar 1;354(Pt 2):233-42. doi: 10.1042/0264-6021:3540233.
9
Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity.
J Biol Chem. 2003 Nov 14;278(46):45746-52. doi: 10.1074/jbc.M308608200. Epub 2003 Aug 28.
10
NMR solution structure of the angiostatic peptide anginex.血管抑制肽Anginex的核磁共振溶液结构
Biochim Biophys Acta. 2007 May;1774(5):645-51. doi: 10.1016/j.bbapap.2007.03.007. Epub 2007 Mar 24.

引用本文的文献

1
Targeting galectin-driven regulatory circuits in cancer and fibrosis.靶向癌症和纤维化中半乳糖凝集素驱动的调控通路
Nat Rev Drug Discov. 2023 Apr;22(4):295-316. doi: 10.1038/s41573-023-00636-2. Epub 2023 Feb 9.
2
The Ionophoric Activity of a Pro-Apoptotic VEGF165 Fragment on HUVEC Cells.促凋亡 VEGF165 片段对 HUVEC 细胞的离子通道活性。
Int J Mol Sci. 2020 Apr 20;21(8):2866. doi: 10.3390/ijms21082866.
3
A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells.一种新型的 galectin-1 介导的放射抵抗机制,涉及宫颈癌 H-Ras 依赖性通路。
Cell Death Dis. 2012 Jan 12;3(1):e251. doi: 10.1038/cddis.2011.120.
4
CLT1 targets angiogenic endothelium through CLIC1 and fibronectin.CLT1 通过 CLIC1 和纤维连接蛋白靶向血管生成内皮细胞。
Angiogenesis. 2012 Mar;15(1):115-29. doi: 10.1007/s10456-011-9247-8. Epub 2011 Dec 28.

本文引用的文献

1
Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.缺氧诱导因子-1阻断对肿瘤放射敏感性的多效性作用。
Cancer Cell. 2005 Aug;8(2):99-110. doi: 10.1016/j.ccr.2005.06.016.
2
The heparin-binding site of antithrombin is crucial for antiangiogenic activity.抗凝血酶的肝素结合位点对于抗血管生成活性至关重要。
Blood. 2005 Sep 1;106(5):1621-8. doi: 10.1182/blood-2005-02-0547. Epub 2005 May 19.
3
A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice.一种与肿瘤血管上的阴离子磷脂结合的单克隆抗体可增强多西他赛对小鼠人乳腺肿瘤的抗肿瘤作用。
Cancer Res. 2005 May 15;65(10):4408-16. doi: 10.1158/0008-5472.CAN-05-0031.
4
Host defense peptides as new weapons in cancer treatment.宿主防御肽作为癌症治疗的新武器。
Cell Mol Life Sci. 2005 Apr;62(7-8):784-90. doi: 10.1007/s00018-005-4560-2.
5
Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption.靶向水通道蛋白-1基因破坏对血管生成和细胞迁移的损害。
Nature. 2005 Apr 7;434(7034):786-92. doi: 10.1038/nature03460.
6
Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers.内皮抑素与含磷脂酰丝氨酸的膜结合及淀粉样纤维的形成。
Biochemistry. 2005 Mar 1;44(8):2857-63. doi: 10.1021/bi048510j.
7
Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells.血管抑素(Anginex)与放射治疗协同作用,通过使内皮细胞对辐射敏感来抑制肿瘤生长。
Int J Cancer. 2005 Jun 10;115(2):312-9. doi: 10.1002/ijc.20850.
8
Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature.血管抑制肽利用血浆纤连蛋白归巢至血管生成的脉管系统。
Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2040-5. doi: 10.1073/pnas.0409844102. Epub 2005 Feb 1.
9
Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino Acid Peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion.
Cancer Res. 2004 Aug 15;64(16):5779-86. doi: 10.1158/0008-5472.CAN-04-1438.
10
Inhibition of angiogenesis by Abeta peptides.β-淀粉样肽对血管生成的抑制作用。
Angiogenesis. 2004;7(1):75-85. doi: 10.1023/B:AGEN.0000037335.17717.bf.